Ticker

Vivos Therapeutics, Inc. (NASDAQ: VVOS - Get Free Report) shares traded up 1.5% during trading on Wednesday. The company traded as high as $1.45 and last traded at $1.34. 257,368 shares traded hands during trading, an increase of 168% from the average session volume of 95,931 shares. The stock had previously closed at $1.32. Wall

LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders and associated chronic health conditions, today announced that an a recent study published in the Journal of Clinical Medicine supports Vivos' long maintained belief that dental…

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Vivos Therapeutics, Inc. (NASDAQ: VVOS - Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totaling 415,924 shares, a growth of 47.4% from the December 31st total of 282,105 shares. Based on an average daily volume of 161,860 shares, the days-to-cover ratio

LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing disorders, including obstructive sleep apnea (OSA), today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 1,982,356 shares…